Literature DB >> 2225553

IgA nephritis in Behçet's disease: case report and review of the literature.

Y Akutsu1, N Itami, M Tanaka, Y Kusunoki, H Tochimaru, Y Takekoshi.   

Abstract

We describe a 13-year-old girl with the incomplete type of Behçet's disease who had recurrent oral and genital ulcers, folliculitis, proteinuria and hematuria. Renal biopsy specimens revealed diffuse proliferative glomerulonephritis with strongly positive IgA deposits in the glomerular mesangial area, which is histologically indistinguishable from primary IgA nephritis. Further studies of the IgA subclasses showed that IgA1 deposits were predominant in the glomerular mesangium. Primary IgA nephritis is thought to be associated with polymeric IgA1. So it appears that there may be a common underlying disease or mechanism involved in both primary IgA nephritis and the IgA nephritis in Behçet's disease.

Entities:  

Mesh:

Year:  1990        PMID: 2225553

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  5 in total

Review 1.  Behçet's disease.

Authors:  V Kontogiannis; R J Powell
Journal:  Postgrad Med J       Date:  2000-10       Impact factor: 2.401

2.  A case of IgA nephropathy with deep venous thrombosis in the mesentery and lower extremities.

Authors:  Hong Tang; Lei Zhang; Wei Zhao; Rongquan Chen; Min Xie
Journal:  Quant Imaging Med Surg       Date:  2018-12

3.  Behcet's disease and IgA nephropathy.

Authors:  Mustafa Altay; Sema Secilmis; Selman Unverdi; Mevlut Ceri; Murat Duranay
Journal:  Rheumatol Int       Date:  2011-07-23       Impact factor: 2.631

4.  Renal manifestations in 2007 Korean patients with Behçet's disease.

Authors:  Sung Bin Cho; Jihyun Kim; Shin-Wook Kang; Tae-Hyun Yoo; Zhenlong Zheng; Suhyun Cho; Hye Sun Lee; Dongsik Bang
Journal:  Yonsei Med J       Date:  2013-01-01       Impact factor: 2.759

Review 5.  The "other" vasculitis syndromes and kidney involvement.

Authors:  Seza Ozen
Journal:  Pediatr Nephrol       Date:  2009-11-07       Impact factor: 3.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.